company background image
301239 logo

Chengdu Bright Eye Hospital Group SZSE:301239 Stock Report

Last Price

CN¥49.35

Market Cap

CN¥7.4b

7D

-4.8%

1Y

-47.4%

Updated

22 Nov, 2024

Data

Company Financials +

Chengdu Bright Eye Hospital Group Co., Ltd.

SZSE:301239 Stock Report

Market Cap: CN¥7.4b

301239 Stock Overview

A specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. More details

301239 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends1/6

Chengdu Bright Eye Hospital Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chengdu Bright Eye Hospital Group
Historical stock prices
Current Share PriceCN¥49.35
52 Week HighCN¥103.50
52 Week LowCN¥28.48
Beta1.17
11 Month Change18.35%
3 Month Change57.62%
1 Year Change-47.42%
33 Year Changen/a
5 Year Changen/a
Change since IPO-6.39%

Recent News & Updates

After Leaping 25% Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Shares Are Not Flying Under The Radar

Nov 19
After Leaping 25% Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Shares Are Not Flying Under The Radar

Recent updates

After Leaping 25% Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Shares Are Not Flying Under The Radar

Nov 19
After Leaping 25% Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Shares Are Not Flying Under The Radar

Chengdu Bright Eye Hospital (SZSE:301239) Seems To Use Debt Quite Sensibly

Aug 15
Chengdu Bright Eye Hospital (SZSE:301239) Seems To Use Debt Quite Sensibly

Chengdu Bright Eye Hospital's (SZSE:301239) Upcoming Dividend Will Be Larger Than Last Year's

Jul 19
Chengdu Bright Eye Hospital's (SZSE:301239) Upcoming Dividend Will Be Larger Than Last Year's

Chengdu Bright Eye Hospital (SZSE:301239) Is Reinvesting At Lower Rates Of Return

Jul 18
Chengdu Bright Eye Hospital (SZSE:301239) Is Reinvesting At Lower Rates Of Return

Returns On Capital At Chengdu Bright Eye Hospital (SZSE:301239) Paint A Concerning Picture

Apr 11
Returns On Capital At Chengdu Bright Eye Hospital (SZSE:301239) Paint A Concerning Picture

Shareholder Returns

301239CN HealthcareCN Market
7D-4.8%-0.1%-0.9%
1Y-47.4%-13.3%5.4%

Return vs Industry: 301239 underperformed the CN Healthcare industry which returned -13.3% over the past year.

Return vs Market: 301239 underperformed the CN Market which returned 5.4% over the past year.

Price Volatility

Is 301239's price volatile compared to industry and market?
301239 volatility
301239 Average Weekly Movement14.3%
Healthcare Industry Average Movement8.6%
Market Average Movement8.3%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 301239's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 301239's weekly volatility has increased from 9% to 14% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a4,918Qiang Sunwww.purui.cn

Chengdu Bright Eye Hospital Group Co., Ltd., a specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. Its ophthalmology institutions provide diagnosis, treatment, health care, and medical optometry for patients with ophthalmic diseases in the areas of refractive surgery, cataract, ophthalmology, fundus disease, glaucoma, strabismus and pediatric ophthalmology, lacrimal duct, cornea orbital disease, eye trauma, medical optometry, and other general ophthalmology diagnosis and treatment items. The company was formerly known as Chengdu Bright Eye Hospital Co., Ltd.

Chengdu Bright Eye Hospital Group Co., Ltd. Fundamentals Summary

How do Chengdu Bright Eye Hospital Group's earnings and revenue compare to its market cap?
301239 fundamental statistics
Market capCN¥7.38b
Earnings (TTM)-CN¥33.49m
Revenue (TTM)CN¥2.69b

2.7x

P/S Ratio

-219.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301239 income statement (TTM)
RevenueCN¥2.69b
Cost of RevenueCN¥1.54b
Gross ProfitCN¥1.15b
Other ExpensesCN¥1.18b
Earnings-CN¥33.49m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.22
Gross Margin42.83%
Net Profit Margin-1.25%
Debt/Equity Ratio26.4%

How did 301239 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

-174%

Payout Ratio